We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+8.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$51.1B
AUM Growth
+$2.09B
(+4.3%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
22.51%
Holding
1,173
New
222
Increased
229
Reduced
441
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
+$190M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$171M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$139M |
| 4 |
Textron
TXT
|
+$133M |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$325M |
| 2 |
EOG Resources
EOG
|
+$245M |
| 3 |
Honeywell
HON
|
+$186M |
| 4 |
Merck
MRK
|
+$149M |
| 5 |
Kohl's
KSS
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.75% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 14.77% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Communication Services | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Regeneron Pharmaceuticals
REGN
$78.5B
| $54M | 0.11% |
96,706
+48,300
| +100% | +$24.5M |
|
202
GFL Environmental
GFL
$14.9B
| $53.4M | 0.1% |
+1,673,068
| New | +$54.8M |
|
203
Southwest Airlines
LUV
$22B
| $52.8M | 0.1% |
994,377
+334,500
| +51% | +$20M |
|
|
PNTM
204
DELISTED
Pontem Corporation
PNTM
| $52.5M | 0.1% |
5,400,000
| – | – |
|
205
Travere Therapeutics
TVTX
$5.2B
| $52.4M | 0.1% |
3,593,763
-956,237
| -21% | -$18.9M |
|
206
O'Reilly Automotive
ORLY
$72.9B
| $51.8M | 0.1% |
1,371,000
-27,000
| -2% | -$969K |
|
207
GCM Grosvenor
GCMG
$754M
| $51.5M | 0.1% |
4,942,786
-246,245
| -5% | -$2.91M |
|
208
Illumina
ILMN
$31B
| $51.4M | 0.1% |
111,648
-29,606
| -21% | -$11.9M |
|
209
KLA
KLAC
$239B
| $51.3M | 0.1% |
1,582,700
+50,000
| +3% | +$1.6M |
|
210
Marathon Petroleum
MPC
$92.4B
| $50.7M | 0.1% |
838,660
-216,600
| -21% | -$12.7M |
|
211
IQVIA
IQV
$38.7B
| $50.5M | 0.1% |
208,200
-5,000
| -2% | -$1.15M |
|
212
PG&E
PCG
$38.3B
| $50.3M | 0.1% |
4,950,000
+1,494,738
| +43% | +$16M |
|
213
Public Storage
PSA
$60.5B
| $49.1M | 0.1% |
163,292
-4,000
| -2% | -$1.12M |
|
214
Otis Worldwide
OTIS
$27.4B
| $49M | 0.1% |
598,905
-952,000
| -61% | -$73.3M |
|
215
MetLife
MET
$61.9B
| $48.7M | 0.1% |
813,126
-24,400
| -3% | -$1.55M |
|
216
MSCI
MSCI
$41.6B
| $48.2M | 0.09% |
90,400
-2,200
| -2% | -$1.05M |
|
217
Ross Stores
ROST
$80.5B
| $47.9M | 0.09% |
386,521
-9,300
| -2% | -$1.16M |
|
218
Phillips 66
PSX
$84.9B
| $47.5M | 0.09% |
553,301
+63,600
| +13% | +$5.37M |
|
219
Ecolab
ECL
$78.1B
| $47.5M | 0.09% |
230,425
+11,500
| +5% | +$2.5M |
|
220
Chipotle Mexican Grill
CMG
$47.2B
| $47.1M | 0.09% |
1,519,950
-35,000
| -2% | -$999K |
|
221
Biogen
BIIB
$30B
| $46.9M | 0.09% |
135,399
-36,588
| -21% | -$11.1M |
|
222
Penumbra
PEN
$12.7B
| $46.6M | 0.09% |
170,000
+32,500
| +24% | +$8.87M |
|
223
Simon Property Group
SPG
$74.4B
| $46.4M | 0.09% |
355,963
-8,600
| -2% | -$1.07M |
|
|
SWTX
224
DELISTED
SpringWorks Therapeutics
SWTX
| $46.4M | 0.09% |
563,468
-4,467
| -0.8% | -$339K |
|
225
Teledyne Technologies
TDY
$30.4B
| $46.1M | 0.09% |
+110,185
| New | +$46.8M |
|
Similar funds
Adage Capital Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Adage Capital Partners held 1,173 positions worth $51.1B, up 4.3% from $49B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Adage Capital Partners's Q2 2021 filing shows 222 new, 229 increased, 441 reduced and 163 closed positions. Its largest new stake was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $325M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q2 2021 buy was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M.
- Adage Capital Partners added most to CIMAREX ENERGY CO in Q2 2021, an estimated $190M increase.
- Adage Capital Partners's biggest Q2 2021 reduction was EOG Resources, cutting an estimated $245M.
- Adage Capital Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $325M.
- Adage Capital Partners's ten largest holdings make up 23% of its $51.1B portfolio in Q2 2021.
- Adage Capital Partners opened 222 new positions and closed 163 in Q2 2021.
- Adage Capital Partners's portfolio value rose 4.3% quarter-over-quarter to $51.1B.
Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.